Digitalis has been used to treat heart failure for more than 200 years. The drug digitoxin also belongs to this group of active ingredients known as cardiac glycosides.
Aug 29, 2025
0
51
Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as cardiomyocytes—and the heart's limited regenerative capacity often lead to chronic heart failure. ...
Aug 1, 2025
0
29
People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's annual meeting in San ...
Jul 12, 2025
0
3
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that many of those patients are elderly and have complex medical needs.
Jun 17, 2025
0
0
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there have been questions as to whether it is safe to use these drugs in patients after a recent heart ...
Jun 13, 2025
0
16
New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to significantly greater reductions in albuminuria than either agent alone in patients with chronic kidney disease ...
Jun 5, 2025
0
0
A "substantial number" of dementia cases in the U.S. could be eliminated by reducing cardiometabolic conditions such as heart attack, stroke and diabetes, according to a new study from Barrow Neurological Institute in Phoenix.
May 24, 2025
0
1
Heart failure represents one of the most significant global health challenges, affecting millions worldwide and requiring subsequent hospitalization for many patients due to complications. For older adults in particular, ...
May 19, 2025
0
0
A rapidly growing heart failure epidemic calls for prioritizing primary prevention, according to a new scientific statement from the American Heart Association published in Circulation in April. The statement reviews the ...
May 5, 2025
0
0
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides effective protection against respiratory syncytial virus-related lower respiratory tract disease (RSV-LRTD) ...
